Skip to content
Femasys Logo
Main Menu
  • Corporate
    • About Femasys
      • Who we are
      • Leadership
    • Investor Relations
      • Overview
      • News
      • Events & Presentations
      • Stock Info
      • Financials
      • Governance
      • Resources
    • Resources
    • Contact Us
      • Contact Femasys
      • Join Us
  • Healthcare Professionals
    • Infertility
      • FemaSeed
      • FemVue
    • Birth Control
    • Cancer Diagnosis
  • Patients
    • Infertility
      • FemVue
      • FemaSeed
    • Birth Control
    • Cancer Diagnosis

Category: Media

Providing Safe and Accessible Options for Women’s Reproductive Care

Women’s Healthcare: Will Changing Laws Inhibit Latest Innovations in Fertility and Birth Control Treatments?

Femasys CEO Talks Results of the Femaseed Pivotal Trial and the History of Fembloc Birth Control

Register Now: Femasys Webcast at the Jones Healthcare Seaside Summit 2024

Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the Company to Begin Commercialization Efforts in Europe

EXCLUSIVE: Femasys At Inflection Point And Undervalued, Expects Growth Potential Following Roe v. Wade Overturn, CEO Says

Indiana reports 98% drop in abortions after curbs

‘Don’t Just Give Out the Work — Do the Work’: How This Women’s Healthcare CEO Leads With Passion

UPDATED: Industry hails Supreme Court’s decision to maintain mifepristone abortion pill’s access

Health Tech: Kathy Lee-Sepsick of Femasys On How Their Technology Can Make An Important Impact On Our Overall Wellness

← older
newer →
About Femasys
  • Who We Are
  • Leadership
Investor Relations
  • Overview
  • News
  • Event & Presentations
  • Stock Info
  • Financials
  • Governance
  • Resources
Resources
  • Who We Are
  • Leadership
Contact Us
  • Contact Femasys
  • Join Us
Healthcare Professionals
  • Infertility
  • Birth Control
  • Cancer Diagnosis
Patients
  • Infertility
  • Birth Control
  • Cancer Diagnosis
Privacy Policy
Terms of Use
Patents
Accessibility
Order
Copyright © 2024 Femasys Inc.
FemaSeed, FemBloc, FemCath, FemCerv, and FemVue are registered trademarks of Femasys Inc.
Main Menu
  • Corporate
    • About Femasys
      • Who we are
      • Leadership
    • Investor Relations
      • Overview
      • News
      • Events & Presentations
      • Stock Info
      • Financials
      • Governance
      • Resources
    • Resources
    • Contact Us
      • Contact Femasys
      • Join Us
  • Healthcare Professionals
    • Infertility
      • FemaSeed
      • FemVue
    • Birth Control
    • Cancer Diagnosis
  • Patients
    • Infertility
      • FemVue
      • FemaSeed
    • Birth Control
    • Cancer Diagnosis